Learn / Stock guides / REGN
NASDAQ: REGNRegeneron Pharmaceuticals (REGN) stock, explained like you're 5
Regeneron Pharmaceuticals trades on the Nasdaq under the ticker REGN. It is a large cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 75.7 billion dollars.
- Ticker
- REGN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Size
- Large cap, about 75.7 billion dollars
How Regeneron Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves REGN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Did Regeneron Pharmaceuticals (REGN) Stock Drop Today? (Yahoo Finance)
- Regeneron (REGN) Stock May Be Underpriced Despite Its $1b Alliance Expansion (Simply Wall Street)
- Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30? (The Motley Fool)
- Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day (MarketWatch)
- Four antibodies join a deal that pays Regeneron $1 billion upfront, with up to $7 billion more possible. (Stock Titan)
Follow REGN in your daily brief
Each trading day at 5 PM ET we post what happened to Regeneron Pharmaceuticals and why it matters, in plain English. Free.
Start my free briefKey terms to know before you follow REGN
Questions about Regeneron Pharmaceuticals stock
What does Regeneron Pharmaceuticals do?
Regeneron Pharmaceuticals trades on the Nasdaq under the ticker REGN. It is a large cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 75.7 billion dollars.
What is the ticker symbol for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals trades under the ticker REGN on the Nasdaq.
How does Regeneron Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves REGN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow REGN stock every day?
Add REGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in plain English.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.